SRPT
Sarepta Therapeutics Inc
Price:  
124.65 
USD
Volume:  
1,243,842.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 7.4%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 7.80%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 4.55%.

Range Selected
Cost of equity 6.60% - 9.00% 7.80%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 5.10% 4.55%
WACC 6.3% - 8.6% 7.4%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.00%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.1 0.1
Cost of debt 4.00% 5.10%
After-tax WACC 6.3% 8.6%
Selected WACC 7.4%